Cinacalcet
Drug Category | Drug | IHD Dosing | Administration Timing Around HD Session |
---|---|---|---|
Metabolic Bone Disease Medications | Cinacalcet | 30-180mg PO Q24H | Administer Anytime During HD |
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
---|---|---|---|---|---|---|---|
357 | <1 | 30-40 | N/A | 93-97 | 14.2 (based on 70 kg) | N/A | N/A |
References:
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB01012
- Padhi D, Harris R. Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride. Clinical pharmacokinetics 2009; 48(5), 303-11.